Incretin-based therapies for the management of cardiometabolic disease in the clinic: Past, present, and future.
臨床上基於胰高血糖素樣肽的療法在心代謝疾病管理中的應用:過去、現在與未來。
Med Res Rev 2024-08-14
Use and Interchange of Incretin Mimetics in the Treatment of Metabolic Diseases: A Narrative Review.
胰高血糖素類似物在治療代謝性疾病中的使用與互換:敘事性回顧。
Clin Ther 2023-05-10
The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist.
Tirzepatide的心血管效應:一種葡萄糖樣胰島素樣肽和葡萄糖依賴性胰島素樣肽雙重激動劑。
J Lipid Atheroscler 2023-10-26
Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.
Tirzepatide的療效和安全性:一項針對第2型糖尿病管理的雙GLP-1/GIP受體激動劑的系統性回顧和隨機對照試驗的荟萃分析。
Diabetol Metab Syndr 2023-11-02
Tirzepatide: A novel cardiovascular protective agent in type 2 diabetes mellitus and obesity.
Tirzepatide:一種新型心血管保護劑在第2型糖尿病和肥胖症中。
Curr Probl Cardiol 2024-04-02
Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide.
將「Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide.」翻譯為「GLP1受體激動劑與心血管結果之間的鴻溝:tirzepatide角色的證據。」
Cardiovasc Diabetol 2024-07-10
GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management.
肥胖中 GLP-1 生理學及基於促胰島素的藥物在慢性體重管理中的發展。
Nat Metab 2024-08-19
Tirzepatide's innovative applications in the management of type 2 diabetes and its future prospects in cardiovascular health.
Tirzepatide 在 2 型糖尿病管理中的創新應用及其在心血管健康中的未來前景。
Front Pharmacol 2024-09-12